These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Chloramphenicol in ophthalmic instillation and risk of generalized sensitization]. Verin P; Sekkat A; Morax S Bull Soc Ophtalmol Fr; 1972 Mar; 72(3):365-70. PubMed ID: 4643424 [No Abstract] [Full Text] [Related]
3. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. Wiholm BE; Kelly JP; Kaufman D; Issaragrisil S; Levy M; Anderson T; Shapiro S BMJ; 1998 Feb; 316(7132):666. PubMed ID: 9522791 [No Abstract] [Full Text] [Related]
4. Use of chloramphenicol as topical eye medication: time to cry halt? Doona M; Walsh JB BMJ; 1995 May; 310(6989):1217-8. PubMed ID: 7767184 [No Abstract] [Full Text] [Related]
5. Is it time to stop using chloramphenicol on the eye? General practitioners would expect to see aplasia roughly once each century. Cox J; Roderick EM BMJ; 1995 Aug; 311(7002):451; author reply 451. PubMed ID: 7640601 [No Abstract] [Full Text] [Related]
6. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Flach AJ Am J Ophthalmol; 1982 Sep; 94(3):420-2. PubMed ID: 7124889 [No Abstract] [Full Text] [Related]
7. Chloramphenicol and aplastic anemia. Flach AJ Am J Ophthalmol; 1982 May; 93(5):664-6. PubMed ID: 7081370 [No Abstract] [Full Text] [Related]
8. Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer. Gordon-Smith EC; Marsh JC; Geary CG BMJ; 1995 Aug; 311(7002):451. PubMed ID: 7640600 [No Abstract] [Full Text] [Related]
10. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Fraunfelder FT; Bagby GC; Kelly DJ Am J Ophthalmol; 1982 Mar; 93(3):356-60. PubMed ID: 7072798 [TBL] [Abstract][Full Text] [Related]
11. Marrow aplasia following topical application of chloramphenicol eye ointment. Abrams SM; Degnan TJ; Vinciguerra V Arch Intern Med; 1980 Apr; 140(4):576-7. PubMed ID: 7362398 [TBL] [Abstract][Full Text] [Related]
12. Aplastic anemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature. Issaragrisil S; Piankijagum A J Med Assoc Thai; 1985 Jun; 68(6):309-12. PubMed ID: 4056637 [No Abstract] [Full Text] [Related]
13. Chloramphenicol eye drops and blood dyscrasia. McGuinness R Med J Aust; 1984 Mar; 140(6):383. PubMed ID: 6700500 [No Abstract] [Full Text] [Related]
14. Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Brodsky E; Biger Y; Zeidan Z; Schneider M Isr J Med Sci; 1989 Jan; 25(1):54. PubMed ID: 2925363 [No Abstract] [Full Text] [Related]
15. Is it time to stop using chloramphenicol on the eye? Risk is low in short courses. Hall AV; Das SS; Tabaqchali S BMJ; 1995 Aug; 311(7002):450-1; author reply 451. PubMed ID: 7640599 [No Abstract] [Full Text] [Related]
16. [Systemic side effects due to external application of chloramphenicol]. Hautarzt; 1985 Mar; 36(3):181-3. PubMed ID: 3997517 [No Abstract] [Full Text] [Related]
19. Topical chloramphenicol for eye infections. Lam RF; Lai JS; Ng JS; Rao SK; Law RW; Lam DS Hong Kong Med J; 2002 Feb; 8(1):44-7. PubMed ID: 11861993 [TBL] [Abstract][Full Text] [Related]
20. It is time to stop using topical chloramphenicol. Smith JR; Wesselingh S; Coster DJ Aust N Z J Ophthalmol; 1997 Feb; 25(1):83-8. PubMed ID: 9107404 [No Abstract] [Full Text] [Related] [Next] [New Search]